RANI THERAPEUTICS HOLDINGS, INC. (RANI) Return on equity 2021–2025
RANI THERAPEUTICS HOLDINGS, INC. (RANI) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-89.9%FY2025 · since FY2021: -17.6% → -89.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -89.9% | +1417.0 pp |
| FY2024 | -1506.9% | -1242.9 pp |
| FY2023 | -264.0% | -181.0 pp |
| FY2022 | -83.0% | -65.4 pp |
| FY2021 | -17.6% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More RANI financial trends
RANI RevenueRANI Net incomeRANI Net marginRANI Gross profitRANI Gross marginRANI Operating incomeRANI Operating marginRANI Operating cash flowRANI Free cash flowRANI Capital expendituresRANI Stock buybacksRANI Dividends paidRANI Total assetsRANI Total liabilitiesRANI Shareholders’ equityRANI overview →